
GSK Plc ADR (GSK) Stock: A Closer Look at the Moving Averages
The stock of GSK Plc ADR (GSK) has seen a -3.77% decrease in the past week, with a 2.66% gain in the past month, and
The stock of GSK Plc ADR (GSK) has seen a -3.77% decrease in the past week, with a 2.66% gain in the past month, and
The stock price of GSK Plc ADR (NYSE: GSK) has dropped by -0.56 compared to previous close of 39.07. Despite this, the company has seen
GSK Plc ADR (NYSE: GSK) has a price-to-earnings ratio that is above its average at 23.03x. The stock has a 36-month beta value of 0.54.
GSK Plc ADR (NYSE: GSK) has a price-to-earnings ratio that is above its average at 21.89x. The stock has a 36-month beta value of 0.57.
The price-to-earnings ratio for GSK Plc ADR (NYSE: GSK) is above average at 22.02x, Company’s 36-month beta value is 0.52.Analysts have differing opinions on the
GSK Plc ADR (NYSE: GSK)’s stock price has gone decline by -1.55 in comparison to its previous close of 38.74, however, the company has experienced
GSK Plc ADR (NYSE: GSK) has a higher price-to-earnings ratio of 24.47x compared to its average ratio, The 36-month beta value for GSK is at
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.